Toll Free: 1-888-928-9744

bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2016 Update

Published: Apr 27, 2016 | Pages: 69 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy l'Etoile, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company bioMerieux S.A.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 5 List of Figures 7 bioMerieux S.A. Company Snapshot 8 bioMerieux S.A. Company Overview 8 bioMerieux S.A. Pipeline Products and Clinical Trials Overview 9 bioMerieux S.A. - Pipeline Analysis Overview 12 Business Description 12 Key Facts 12 bioMerieux S.A. - Major Products and Services 13 bioMerieux S.A. Pipeline Products by Development Stage 15 bioMerieux S.A. Clinical Trials by Trial Status 18 bioMerieux S.A. Pipeline Products Overview 20 Annexin A3 Prostate Cancer Marker 20 Annexin A3 Prostate Cancer Marker Product Overview 20 BRAF - Breast Cancer Diagnostic Kit 21 BRAF - Breast Cancer Diagnostic Kit Product Overview 21 Breast Cancer Index 22 Breast Cancer Index Product Overview 22 Breast Cancer Index Clinical Trial 23 CancerTARGET ID 24 CancerTARGET ID Product Overview 24 CancerTREATMENT ID 25 CancerTREATMENT ID Product Overview 25 CancerTYPE ID 26 CancerTYPE ID Product Overview 26 Companion Diagnostic Test - Hormone-Dependent Breast Cancer 27 Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview 27 Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor 28 Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview 28 Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor 29 Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview 29 Companion Diagnostic Test - Hormone-Dependent Prostate Cancer 30 Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview 30 Diagnostic Assay - Prostate Cancer 31 Diagnostic Assay - Prostate Cancer Product Overview 31 Diagnostic Test - Colorectal Cancer 32 Diagnostic Test - Colorectal Cancer Product Overview 32 Diagnostic Test - Tuberculosis 33 Diagnostic Test - Tuberculosis Product Overview 33 FilmArray Biothreat-E Test 34 FilmArray Biothreat-E Test Product Overview 34 FilmArray Direct Sepsis Panel 35 FilmArray Direct Sepsis Panel Product Overview 35 FilmArray Meningitis Panel 36 FilmArray Meningitis Panel Product Overview 36 FilmArray Pneumonia Pathogen Panel 37 FilmArray Pneumonia Pathogen Panel Product Overview 37 FilmArray STD Panel 38 FilmArray STD Panel Product Overview 38 FilmArray Torch 39 FilmArray Torch Product Overview 39 iMAG 40 iMAG Product Overview 40 Magnotech System 41 Magnotech System Product Overview 41 Magnotech System - Cardiovascular Disease Assay 42 Magnotech System - Cardiovascular Disease Assay Product Overview 42 NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test 43 NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview 43 NucliSENS EasyQ Legionella spp Molecular Test 44 NucliSENS EasyQ Legionella spp Molecular Test Product Overview 44 NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test 45 NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview 45 Screening Biomarker Assay - Prostate Cancer 46 Screening Biomarker Assay - Prostate Cancer Product Overview 46 VIDAS CRP Assay 47 VIDAS CRP Assay Product Overview 47 bioMerieux S.A. - Key Competitors 48 bioMerieux S.A. - Key Employees 49 bioMerieux S.A. - Key Employee Biographies 50 bioMerieux S.A. - Locations And Subsidiaries 51 Head Office 51 Other Locations & Subsidiaries 51 Recent Developments 56 bioMerieux S.A., Recent Developments 56 Apr 20, 2016: bioMerieux - First-Quarter 2016 Business Review 56 Apr 19, 2016: Biotheranostics to Present Feasibility Data of Gene Expression Profiling in Blood 57 Apr 08, 2016: FilmArray Torch is now FDA cleared with all 4 existing FilmArray Panels and the system gets CE marked 58 Mar 22, 2016: bioMerieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories 59 Mar 02, 2016: bioMerieux - 2015 Financial Results 60 Jan 26, 2016: BioFire's FilmArray Meningitis/Encephalitis Panel Gets CE Marked 63 Jan 21, 2016: bioMerieux - Fourth-Quarter 2015 Business Review 64 Jan 12, 2016: BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray Torch, the New High Throughput FilmArray System with FilmArray Respiratory Panel 66 Dec 14, 2015: bioMerieux and Illumina announce the launch of bioMerieux EpiSeq, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections 67 Dec 08, 2015: Studies Demonstrate Broadening Clinical Utility of bioTheranostics' Breast Cancer Index Molecular Test in the Extended Endocrine Therapy Setting 67 Appendix 69 Methodology 69 About GlobalData 69 Contact Us 69 Disclaimer 6
List of Tables
bioMerieux S.A. Pipeline Products and Clinical Trials Overview 9 bioMerieux S.A. Pipeline Products by Equipment Type 9 bioMerieux S.A. Pipeline Products by Indication 11 bioMerieux S.A. Clinical Trials by Trial Status 11 bioMerieux S.A., Key Facts 12 bioMerieux S.A., Major Products and Services 13 bioMerieux S.A. Number of Pipeline Products by Development Stage 15 bioMerieux S.A. Pipeline Products Summary by Development Stage 16 bioMerieux S.A. Clinical Trials by Trial Status 18 bioMerieux S.A. Clinical Trials Summary 19 Annexin A3 Prostate Cancer Marker - Product Status 20 Annexin A3 Prostate Cancer Marker - Product Description 20 BRAF - Breast Cancer Diagnostic Kit - Product Status 21 BRAF - Breast Cancer Diagnostic Kit - Product Description 21 Breast Cancer Index - Product Status 22 Breast Cancer Index - Product Description 22 Breast Cancer Index - BioTheranostics Breast Cancer IndexSM Molecular Test Identifies Risk for Early and Late Breast Cancer Recurrence, Lancet Oncology Study Finds: A Prospective Randomized Trial 23 Breast Cancer Index - Clinical Utilization of Breast Cancer Index (BCI), a Gene Expression-based Assay for Prediction of Late Recurrence and Benefit from Extended Endocrine Therapy 23 CancerTARGET ID - Product Status 24 CancerTARGET ID - Product Description 24 CancerTREATMENT ID - Product Status 25 CancerTREATMENT ID - Product Description 25 CancerTYPE ID - Product Status 26 CancerTYPE ID - Product Description 26 Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status 27 Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description 27 Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status 28 Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description 28 Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status 29 Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description 29 Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status 30 Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description 30 Diagnostic Assay - Prostate Cancer - Product Status 31 Diagnostic Assay - Prostate Cancer - Product Description 31 Diagnostic Test - Colorectal Cancer - Product Status 32 Diagnostic Test - Colorectal Cancer - Product Description 32 Diagnostic Test - Tuberculosis - Product Status 33 Diagnostic Test - Tuberculosis - Product Description 33 FilmArray Biothreat-E Test - Product Status 34 FilmArray Biothreat-E Test - Product Description 34 FilmArray Direct Sepsis Panel - Product Status 35 FilmArray Direct Sepsis Panel - Product Description 35 FilmArray Meningitis Panel - Product Status 36 FilmArray Meningitis Panel - Product Description 36 FilmArray Pneumonia Pathogen Panel - Product Status 37 FilmArray Pneumonia Pathogen Panel - Product Description 37 FilmArray STD Panel - Product Status 38 FilmArray STD Panel - Product Description 38 FilmArray Torch - Product Status 39 FilmArray Torch - Product Description 39 iMAG - Product Status 40 iMAG - Product Description 40 Magnotech System - Product Status 41 Magnotech System - Product Description 41 Magnotech System - Cardiovascular Disease Assay - Product Status 42 Magnotech System - Cardiovascular Disease Assay - Product Description 42 NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status 43 NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description 43 NucliSENS EasyQ Legionella spp Molecular Test - Product Status 44 NucliSENS EasyQ Legionella spp Molecular Test - Product Description 44 NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status 45 NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description 45 Screening Biomarker Assay - Prostate Cancer - Product Status 46 Screening Biomarker Assay - Prostate Cancer - Product Description 46 VIDAS CRP Assay - Product Status 47 VIDAS CRP Assay - Product Description 47 bioMerieux S.A., Key Employees 49 bioMerieux S.A., Key Employee Biographies 50 bioMerieux S.A., Other Locations 51 bioMerieux S.A., Subsidiaries 51


List of Figures
bioMerieux S.A. Pipeline Products by Equipment Type 10 bioMerieux S.A. Pipeline Products by Development Stage 15 bioMerieux S.A. Clinical Trials by Trial Status 18

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global aerospace plastics market size is likely to be valued at USD 13.48 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing application scope of lightweight materials in aerospace industry is likely to drive market growt

Read More...

Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expe

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global adhesives & sealants market size is expected to reach USD 43.19 billion by 2020, as per a new research report by Radiant Insights, Inc. Strong demand from packaging, construction and automotive industries is expected drive adhesives and sealan

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify